MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Explore how genetic testing aids in diagnosing Atrioventricular Septal Defect 5, focusing on genetic mutations, personalized treatments, and early intervention.
Explore Auriculocondylar Syndrome 2, a rare craniofacial condition. Learn how genetic testing aids in diagnosis, management, and family planning strategies.
Unlock the benefits of genetic testing in diagnosing ALPS type 4, enhancing treatment, guiding family planning, and understanding genetic interactions.
Uncover the impact of Autosomal Dominant Aplasia and Myelodysplasia. See how genetic testing aids in diagnosis, treatment, and family planning for hereditary conditions.
Exploring genetic testing for ADNSHL4B, gain insights on early diagnosis, personalized treatment, and genetic counseling for improved hearing loss management.
Explore how PKHD1L1 gene variants linked to Autosomal Recessive Nonsyndromic Hearing Loss 86 are identified through genetic testing for improved diagnosis and care.
Explore the impact of genetic testing on Autosomal Recessive Spinocerebellar Ataxia 16, focusing on early diagnosis, carrier detection, and personalized treatment.
Explore how genetic testing unveils key markers of Autosomal Lupus Erythematosus Type 16, aiding in diagnosis, personalized treatment, and managing disease progression.